IP Library › Granted Patent US 7,514,093
Granted Patent B2
US 7,514,093 · App. 10/543,100 · Granted Apr 7, 2009

Vitreous antimicrobial agent and antimicrobial product

Assignee: Toagosei Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,514,093
App. No.
10/543,100
Granted
Apr 7, 2009
Kind
B2
Abstract

A vitreous antimicrobial agent that can exhibit excellent antimicrobial properties when added to various types of resins, that has excellent discoloration resistance and hot water resistance, and that can easily be produced at a commercial scale. The vitreous antimicrobial agent includes, relative to 100 mass % of total glass components, 0.1 to 2 mass % of Ag 2 O, 40.5 to 49 mass % of ZnO, 6 to 9.5 mass % of SiO 2 , 30.5 to 39.5 mass % of B 2 O 3 , 2 to 10 mass % of an alkaline earth metal oxide, and 6 to 7.5 mass % of Na 2 O; the vitreous antimicrobial agent comprising, in addition to these, 0.01 to 5 mass % of CeO 2 as necessary. An antimicrobial resin composition and an antimicrobial product including the vitreous antimicrobial agent.

Claims (12)

1. A vitreous antimicrobial agent comprising, relative to 100 mass % of total glass components, 0.1 to 2 mass % of Ag 2 O, 40.5 to 49 mass % of ZnO, 6 to 9.5 mass % of SiO 2 , 30.5 to 39.5 mass % of B 2 O 3 , 2 to 10 mass % of an alkaline earth metal oxide, and 6 to 7.5 mass % of Na 2 O.

2. The vitreous antimicrobial agent according to claim 1 , wherein the glass components further comprise 0.01 to 5 mass % of CeO 2 .

3. The vitreous antimicrobial agent according to claim 1 , wherein the vitreous antimicrobial agent is a powder and has an average particle size of 0.1 to 30 μm.

4. An antimicrobial resin composition comprising the vitreous antimicrobial agent according to claim 1 in an amount at which an antimicrobial function is exhibited.

5. An antimicrobial resin composition comprising the vitreous antimicrobial agent according to claim 2 in an amount at which an antimicrobial function is exhibited.

6. An antimicrobial resin composition comprising the vitreous antimicrobial agent according to claim 3 in an amount at which an antimicrobial function is exhibited.

7. An antimicrobial resin composition comprising the vitreous antimicrobial agent according to claim 1 at 0.03 to 5 parts by mass relative to 100 parts by mass of the antimicrobial resin composition.

8. An antimicrobial resin composition comprising the vitreous antimicrobial agent according to claim 2 at 0.03 to 5 parts by mass relative to 100 parts by mass of the antimicrobial resin composition.

9. An antimicrobial resin composition comprising the vitreous antimicrobial agent according to claim 3 at 0.03 to 5 parts by mass relative to 100 parts by mass of the antimicrobial resin composition.

10. An antimicrobial product comprising the vitreous antimicrobial agent according to claim 1 .

11. An antimicrobial product comprising the vitreous antimicrobial agent according to claim 2 .

12. An antimicrobial product comprising the vitreous antimicrobial agent according to claim 3 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2005
From: SUGIURA, KOJI
To: TOAGOSEI CO., LTD.
Reel/Frame 017515/0838 →
Priority Claims (1)
JP 2003-016274 · Jan 24, 2003 · national
Continuity (1)
Related Publication 20060127498A1 · Jun 15, 2006